Goldman Sachs analyst Kash Rangan maintains Zoom Video Comms (NASDAQ:ZM) with a Neutral and lowers the price target from $142 to $122.
Hit With Short Seller Report, Renovaro Biosciences Comments On Hindenburg’s Opinion Piece
Renovaro Biosciences confronts Hindenburg's short report fallout, highlighting tech and business leaders joining the board. Despite false claims, the company asserts confidence.